HOME >> BIOLOGY >> NEWS
Vertex Pharmaceuticals/Yale Research Team Uses Gene Knockout Mice To Establish Role Of Caspase-9 In Neuronal Cell Death Pathway

Cambridge, MA, August 7, 1998 -- A team of scientists from Vertex Pharmaceuticals, Yale University School of Medicine, Howard Hughes Medical Institute (HHMI) at Yale University, and Tokyo Metropolitan Institute of Medical Science (TMI) reported results with a gene knockout mouse that establishes a key role for the enzyme Caspase-9 in a specific biochemical pathway that results in neuronal cell death. These findings, published in the August 7, 1998 issue of Cell, suggest that blocking Caspase-9 may be a viable strategy for treating a variety of acute and chronic age-related neurological diseases, including Alzheimer's disease, Parkinson's disease and stroke.

Caspases comprise a family of enzymes that are being evaluated for their role in a number of diseases, based on their involvement in biochemical pathways of inflammation and of apoptosis (also known as programmed cell death or cell suicide). Apoptosis is an essential component of numerous biological processes, including tissue remodeling, immune system regulation and embryonic development. Abnormal activation of apoptosis, however, is implicated in the development and progression of a number of different human diseases, and links between specific caspases and specific diseases are beginning to be established. The publication of the Cell paper is the first report describing the in vivo function of Caspase-9, and suggests apparent tissue-selective activity among the eleven reported human caspases.

"When mitochondria -- the energy factory of cells -- are damaged, Caspase-9 is activated leading to cell death," said Dr. Richard A Flavell, an HHMI Investigator and an author of the study. "In cells lacking Caspase-9, this damage did not give rise to cell death."

"Our results also indicate that Caspase-9 is activated early and is essential for apoptosis in neuronal cells, and that deletion of Caspase-9 does not interfere with embryonic development of other non-neuronal tissues," said Dr. Keisuke Kuida, St
'"/>

Contact: Michael Partridge
partridge@vpharm.com
(617) 577-6108
Vertex Pharmaceuticals
7-Aug-1998


Page: 1 2 3 4

Related biology news :

1. Research Findings Suggest Potent, Broad-Spectrum Antiviral Activity For Vertexs Investigational IMPDH Inhibitor VX-497
2. Phase III Results Suggest Potent Antiviral Activity For Vertex And Glaxo Wellcomes Second-Generation HIV Protease Inhibitor Agenerase TM
3. Vertex Researchers Report Three-Dimensional Atomic Structure Of JNK3 Enzyme; Report In Structure
4. Vertex Pharmaceuticals Researchers Report Three-Dimensional Structure Of Hepatitis C Helicase Enzyme; Report In Structure
5. Researchers determine genetic cause of Timothy syndrome
6. Researchers find color sensitive atomic switch in bacteria
7. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
8. Researchers identify protein promoting vascular tumor growth
9. Researchers devise potent new tools to curb ivory poaching
10. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
11. Researchers ID chlorophyll-regulating gene

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/8/2019)... ... January 07, 2019 , ... Join industry experts Julie Peacock, Client Services at ... on Thursday, January 17, 2019 at 1pm EST. , This webinar will ... clinical trial process. Featured speakers will also present a case study of a leading ...
(Date:1/7/2019)... ... January 07, 2019 , ... Concerto HealthAI, ... for precision health in oncology and other key therapeutic areas, and its Chief ... investors, entrepreneurs and executives spanning the entire healthcare landscape, on January 8, 2019, ...
(Date:1/4/2019)... ... January 02, 2019 , ... Lifecycle Biotechnologies announces the ... science tools and service supplier turned 40 in 2018 and for the first ... not just part numbers like most catalogs, but rather, insightful information into Lifecycle’s ...
Breaking Biology News(10 mins):
(Date:12/13/2018)... ... December 11, 2018 , ... ... and nurses can use to quickly detect Clostridium difficile (C. diff), a dangerous ... of a handheld device that can be used onsite in doctor’s offices and ...
(Date:12/13/2018)... ... , ... Helping conclude Healthy Aging Month this past September, Signia partners with ... Vision and Hearing campaign that sets out to shed light on various ways to ... to destigmatize hearing aids over the years, 9 out of 10 people with mild ...
(Date:12/10/2018)... ... December 10, 2018 , ... ... and Manufacturing Organization (CDMO) with sites in China and the United States, ... aseptic fill finish solutions for monoclonal antibody (mAb) and antibody-drug conjugate (ADC) ...
(Date:12/5/2018)... ... December 05, 2018 , ... The incredible life story of ... in the European Parliament by Carlos Moedas, the European Commissioner for Research and Innovation. ... Innovation in Our Daily Lives, Commissioner Moedas spoke at length of Yousef’s life and ...
Breaking Biology Technology:
Cached News: